GlassScriptPhysician profile
Ashok C Solsi
NPI 1780685669
$1,446.38
in general payments reported to CMS, 2019-2025
22 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $52.08 · 2021: $28.66 · 2022: $247 · 2023: $262 · 2024: $353 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $279.55 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $272.61 | 2019-2024 | |
| Baxter Healthcare | $175.52 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Abbott Laboratories | $123.24 | 2021-2025 | Mitraclip, Cardiomems, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.96 | 2019-2020 | |
| Astellas Pharma US INC | $75.00 | 2019 | |
| Amgen INC. | $66.06 | 2023 | Repatha |
| Cleerly, INC. | $48.14 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Medtronic, INC. | $41.75 | 2022-2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $40.92 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $24.96 | 2020-2024 | Eliquis |
| Daiichi Sankyo INC. | $24.84 | 2023 | Injectafer |
| Altathera Pharmaceuticals LLC | $22.58 | 2025 | Sotalol Hydrochloride |
| Philips North America LLC | $20.48 | 2023 | |
| Abiomed | $20.41 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.12 | 2024 | |
| Alnylam Pharmaceuticals INC. | $16.94 | 2024 | Amvuttra |
| Siemens Medical Solutions USA, INC. | $16.67 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Merck Sharp & Dohme LLC | $16.49 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.58 | 2019 | |
| Pfizer INC. | $14.02 | 2024 | |
| Tactile Systems Technology INC | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Solsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.